Publications 2021

Tryggestad AMA, Axcrona K, Axcrona U, Bigalke I, Brennhovd B, Inderberg EM, Hønnåshagen TK, Skoge LJ, Solum G, Saebøe-Larssen S, Josefsen D, Olaussen RW, Aamdal S, Skotheim RI, Myklebust TÅ, Schendel DJ, Lilleby W, Dueland S, Kvalheim G (2021)
Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy
Prostate, 82 (2), 245-253
DOI 10.1002/pros.24267, PubMed 34762317

Publications 2009

Førland DT, Johnson E, Tryggestad AM, Lyberg T, Hetland G (2009)
An extract based on the medicinal mushroom Agaricus blazei Murill stimulates monocyte-derived dendritic cells to cytokine and chemokine production in vitro
Cytokine, 49 (3), 245-50
DOI 10.1016/j.cyto.2009.09.002, PubMed 20036142

Publications 2008

Hetland G, Johnson E, Lyberg T, Bernardshaw S, Tryggestad AM, Grinde B (2008)
Effects of the medicinal mushroom Agaricus blazei Murill on immunity, infection and cancer
Scand J Immunol, 68 (4), 363-70
DOI 10.1111/j.1365-3083.2008.02156.x, PubMed 18782264

Publications 2006

Johnsen IB, Nguyen TT, Ringdal M, Tryggestad AM, Bakke O, Lien E, Espevik T, Anthonsen MW (2006)
Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling
EMBO J, 25 (14), 3335-46
DOI 10.1038/sj.emboj.7601222, PubMed 16858407

Publications 2005

Bernardshaw S, Hetland G, Ellertsen LK, Tryggestad AM, Johnson E (2005)
An extract of the medicinal mushroom Agaricus blazei Murill differentially stimulates production of pro-inflammatory cytokines in human monocytes and human vein endothelial cells in vitro
Inflammation, 29 (4-6), 147-53
DOI 10.1007/s10753-006-9010-2, PubMed 17091395